<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7835869/table_5" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 5</label>
  <p>Antineoplastic activity and toxicological data.</p>
 </caption>
 <thead>
  <tr>
   <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">
    <i>Rosa</i> Species 
   </th>
   <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Type of Extract, Fraction, or Compound Investigated</th>
   <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Anticancer and Other Activities Supporting the Anticancer Therapy</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">References</th>
   <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-4-.">Toxicological Data/Safety</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-5-.">References</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td rowspan="3" align="left" valign="middle" colspan="1">
    <b>
     <i>R. damascena</i> Mill. 
    </b>
   </td>
   <td rowspan="3" align="left" valign="middle" colspan="1">
    <b>Essential oil</b>
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Lung cancer cell line A549 (IC 
    <sub>50</sub> = 36.4 µg/mL *); 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B24-biomolecules-11-00127" ref-type="bibr">24</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– No toxic effects in doses up to 10 μg/mL </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B24-biomolecules-11-00127" ref-type="bibr">24</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Significant improvement of cancer patients’ sleep quality regarding sleep latency and duration (5% and 10% essential oil).</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B140-biomolecules-11-00127" ref-type="bibr">140</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Low cytotoxicity towards the normal cell line NIH3T3 (IC 
    <sub>50</sub> = 42.9 µg/mL) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B24-biomolecules-11-00127" ref-type="bibr">24</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1">– not cytotoxic at 200 μg/mL against tumor cell lines HepG2, Hep3B (hepatoma), A549, and breast MCF-7 and MDA-MB-231 cell lines</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B139-biomolecules-11-00127" ref-type="bibr">139</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Significant cytotoxic and genotoxic effects in peripheral blood lymphocytes at doses over 10 µg/mL, 1% (after 1 h exposure) and 0.1% (after 24 h exposure)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B24-biomolecules-11-00127" ref-type="bibr">24</a>, 
    <a rid="B74-biomolecules-11-00127" ref-type="bibr">74</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Vapour and water soluble phases of the essential oil</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">−</p>
      <p>Gastric (MKN45) and colon (SW742) cancer cell line:</p>
      <ul list-type="simple">
       <li class="list-item">
        <p class="label">○</p>
        <p>Vapour phase of the essential oil: decreased cell viability to less than 10%;</p>
       </li>
       <li class="list-item">
        <p class="label">○</p>
        <p>Water soluble phase of the essential oil (1–60 µL): increased cell viability about 9 folds;</p>
       </li>
      </ul>
     </li>
    </ul>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B144-biomolecules-11-00127" ref-type="bibr">144</a>, 
    <a rid="B145-biomolecules-11-00127" ref-type="bibr">145</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">−</p>
      <p>Vapour phase of the essential oil: cytotoxic towards normal human fibroblasts</p>
     </li>
     <li class="list-item">
      <p class="label">−</p>
      <p>Water soluble phase of the essential oil (2–3 μL): potent growth factor for normal fibroblasts</p>
     </li>
    </ul>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B144-biomolecules-11-00127" ref-type="bibr">144</a>, 
    <a rid="B145-biomolecules-11-00127" ref-type="bibr">145</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
    <b>Extracts:</b>
   </td>
   <td align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Essential oil extract (2%) loaded in a self-nanoemulsifying drug delivery system </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Breast MCF7 (10% cell survival) and pancreatic PANC1 (15% cell survival) cancer cell lines</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B135-biomolecules-11-00127" ref-type="bibr">135</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">N.d. **</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Methanol extract</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Cervical cancer cell line HeLa (IC 
    <sub>50</sub> = 265 μg/mL): a selectivity index towards normal kidney epithelial Vero cells SI &gt; 3.8 (SI &gt; 2 means selective toxicity) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B136-biomolecules-11-00127" ref-type="bibr">136</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Low cytotoxicity on normal kidney epithelial Vero cells (IC 
    <sub>50</sub>&gt;1 g/mL) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B136-biomolecules-11-00127" ref-type="bibr">136</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– 50% methanol extract</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Not cytotoxic at 2 μg/mL for 72 h towards U937 human lymphoma cell line.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B138-biomolecules-11-00127" ref-type="bibr">138</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">N.d.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– 50% ethanol extract of flowers</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Cervical cancer cells HeLa (IC 
    <sub>50</sub> (72 h) = 305.1 μg/mL, IC 
    <sub>50</sub> (48 h) = 1540 μg/mL, IC 
    <sub>50</sub> (24 h) = 2135 μg/mL for 24 h) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B73-biomolecules-11-00127" ref-type="bibr">73</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">N.d.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B73-biomolecules-11-00127" ref-type="bibr">73</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– 70% ethanol extract of rose petals</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Mice Ehrlich ascites carcinoma (EAC) cells (IC 
    <sub>80</sub> = 15 μg/mL, 80% growth inhibition at 200 μg/mL); 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Cytotoxic to mice peripheral blood leukocytes: 90% growth inhibition at 200 μg/mL</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– 50% hydroglycol extracts</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Epidermoid carcinoma cell line A431 (IC 
    <sub>50</sub> = 3220 μg/mL) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B143-biomolecules-11-00127" ref-type="bibr">143</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">N.d.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Water extract of petals</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– No cytotoxicity towards EAC cells</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Not cytotoxic to peripheral blood leukocytes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
    <b>Fractions:</b>
   </td>
   <td align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Coumarin fractions of 70% ethanol extract</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Inhibition of EAC cells by approximately 50–70%</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– About 30% inhibition of peripheral blood leukocytes for the monomer fraction</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Phenol glycoside fractions of 70% ethanol extract</td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– Significant inhibition of EAC cells by approximately 85–95% for two of the fractions</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– No significant inhibition of peripheral blood leukocytes </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B142-biomolecules-11-00127" ref-type="bibr">142</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">
    <b>Active substance</b>
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– Isoprenylated aurone</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– Acute myeloid leukemia NB4 (IC 
    <sub>50</sub> = 4.8 μM) and neuroblastoma SHSY5Y (IC 
    <sub>50</sub> = 3.4 μM) cell lines; less cytotoxic to lung A549, prostate PC3 and breast MCF7 cells 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B137-biomolecules-11-00127" ref-type="bibr">137</a>] 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N.d.</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1">
    <b>
     <i>R. damascena</i> Millervar. 
     <i>trigintipetala</i> Dieck (Taif rose) 
    </b>
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <b>Essentialoils, concrete, and absolute</b>
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <ul list-type="simple">
     <li class="list-item">
      <p class="label">− </p>
      <p>Hepatocarcinoma HepG2 cell line:</p>
      <ul list-type="simple">
       <li class="list-item">
        <p class="label">○</p>
        <p>Essential oil: IC 
         <sub>50</sub> = 13 μg/mL *** 
        </p>
       </li>
       <li class="list-item">
        <p class="label">○</p>
        <p>Concrete oil: IC 
         <sub>50</sub> = 16.28 μg /mL *** 
        </p>
       </li>
       <li class="list-item">
        <p class="label">○</p>
        <p>Absolute oil: IC 
         <sub>50</sub> = 24.94 μg /mL 
        </p>
       </li>
      </ul>
     </li>
     <li class="list-item">
      <p class="label">− </p>
      <p>Breast cancer MCF7 cell line:</p>
      <ul list-type="simple">
       <li class="list-item">
        <p class="label">○</p>
        <p>Essential oil: IC 
         <sub>50</sub> = 16 μg/mL *** 
        </p>
       </li>
       <li class="list-item">
        <p class="label">○</p>
        <p>Concrete oil: IC 
         <sub>50</sub> = 18.09μg/mL *** 
        </p>
       </li>
       <li class="list-item">
        <p class="label">○</p>
        <p>Absolute oil: IC 
         <sub>50</sub> = 19.69 μg /mL *** 
        </p>
       </li>
      </ul>
     </li>
    </ul>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B75-biomolecules-11-00127" ref-type="bibr">75</a>, 
    <a rid="B146-biomolecules-11-00127" ref-type="bibr">146</a>] 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– Essential oil was cytotoxically and genotoxically safe at a dose of 10 μg/mL on normal human blood lymphocytes; concrete oil was even less toxic than absolute oil which showed significant antimutagenic activity at a dose of 10 μg/mL</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B75-biomolecules-11-00127" ref-type="bibr">75</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">
    <b>Extracts:</b>
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– Crude 80% methanol extract from fresh and dried roses</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– HepG2 cells (fresh rose extract IC 
    <sub>50</sub> = 9 μg/mL ***, dry rose extract IC 
    <sub>50</sub> = 13 μg/mL ***) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B147-biomolecules-11-00127" ref-type="bibr">147</a>] 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– N.d.</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
  </tr>
  <tr>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">
    <b>Fractions of crude 80% methanol extract from fresh and dried roses:</b>
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"> </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">–  
    <i>n</i>-butanol 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– HepG2 cells (fresh rose extract IC 
    <sub>50</sub> = 17 μg/mL ***, dry rose extract IC 
    <sub>50</sub> = 18 μg/mL ***) 
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[ 
    <a rid="B147-biomolecules-11-00127" ref-type="bibr">147</a>] 
   </td>
   <td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">– N.d.</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">-</td>
  </tr>
  <tr>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– aqueous</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– HepG2 cells (fresh rose extract IC 
    <sub>50</sub> = 8 μg/mL ***, dry rose extract IC 
    <sub>50</sub> = 11 μg/mL ***) 
   </td>
  </tr>
  <tr>
   <td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
    <b>
     <i>R. damascena</i>
    </b>
    <br/>
    <b>“Alexandria” and</b>
    <br/>
    <b>
     <i>R. gallica</i> “Francesa” draft in 
     <i>R. canina</i>
    </b>
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">
    <b>Methanol: water (80:20) extract</b>
    <br/>(from petals) 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– HeLa (IC 
    <sub>50</sub> = 308 μg/mL) and HepG2 (IC 
    <sub>50</sub> = 297 μg/mL) cellslarge cell lung carcinoma cell line NCI-H460 (IC 
    <sub>50</sub>&gt; 400 μg/mL) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B148-biomolecules-11-00127" ref-type="bibr">148</a>] 
   </td>
   <td align="left" valign="middle" rowspan="1" colspan="1">– No hepatoxicity towards the non-tumor porcine liver primary culture (IC 
    <sub>50</sub> &gt; 400 μg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B148-biomolecules-11-00127" ref-type="bibr">148</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <b>Infusion</b>
    <br/>(from petals) 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– MCF-7 (IC 
    <sub>50</sub> = 377 μg/mL) and HepG2 (IC 
    <sub>50</sub> = 315 μg/mL) cellsNCI-H460 cells (IC 
    <sub>50</sub>&gt; 400 μg/mL) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B148-biomolecules-11-00127" ref-type="bibr">148</a>] 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">– N.d.</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>* All IC 
    <sub>50</sub> values presented in the table are obtained using the MTT dye assay or sulphorhodamine-B assay; ** N.d.: no published data; *** Values fall within the National Cancer Institute (NCI) guidelines for a promising agent (IC 
    <sub>50</sub> &lt; 20 μg/mL). 
   </p>
  </p>
 </tfoot>
</table>
